Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Gastroenterology
  • Gastroenterology News
  • Steroids improve liver...

Steroids improve liver test abnormalities in infliximab-induced liver injury: Study

Medha BaranwalWritten by Medha Baranwal Published On 2022-01-05T09:00:04+05:30  |  Updated On 2022-01-05T11:03:15+05:30
Steroids improve liver test abnormalities in infliximab-induced liver injury: Study

Iceland: Liver injury and liver inflammation is a rare side effect of infliximab, a biological medicine used to treat multiple inflammatory diseases. In a recent study involving 36 patients with infliximab-induced liver injury, about half of the patients were treated with steroids. The results, published in the Journal of Hepatology suggest that patients who received steroids...

Iceland: Liver injury and liver inflammation is a rare side effect of infliximab, a biological medicine used to treat multiple inflammatory diseases. In a recent study involving 36 patients with infliximab-induced liver injury, about half of the patients were treated with steroids. The results, published in the Journal of Hepatology suggest that patients who received steroids recovered faster. 

The researchers observed a good treatment response with prompt resolution of liver test abnormalities in patients with prolonged elevations in ALT after cessation of infliximab therapy who were treated with corticosteroids. Moreover, no patients developed a relapse of liver injury following the discontinuation of corticosteroid treatment. Overall, 75% of patients switched to another biologic agent, and no drug-induced liver injury (DILI) was seen due to the second biologic. 

Infliximab is known to be associated with DILI, particularly drug-induced autoimmune hepatitis (DIAIH). DIAIH is treated commonly with corticosteroids but data on the efficacy of corticosteroids in infliximab-induced DILI is limited. Considering this Helgi Kristinn Björnsson, the University of Iceland, Faculty of Medicine, Reykjavik, Iceland, and colleagues aimed to gather some data on the topic.

For this purpose, the patients who were treated with infliximab between 2009-2020 in Iceland and developed elevated liver tests were included. Other specific etiologies of liver enzyme elevations were excluded. Patients treated with corticosteroids were compared to those who did not receive corticosteroids. 

A total of 36 patients with infliximab-induced DILI were identified: median age was 46 years and 28 (78%) were female. 

Following were the study's key findings:

  • Type of liver injury was predominantly hepatocellular (64%).
  • Median peak liver enzymes were: alanine aminotransferase (ALT) 393 U/L, aspartate aminotransferase 283 U/L, alkaline phosphatase 116 U/L, and bilirubin 13 μmol/L.
  • A total of 25 (69%) were positive for anti-nuclear antibody and/or had elevated IgG.
  • Corticosteroids were initiated in 17 (47%).
  • Median time from onset of liver injury to peak ALT value was longer in patients treated with corticosteroids, 22 vs. 0 days.
  • Time from peak ALT to normalization of liver enzymes was 45 days in the corticosteroid group vs. 77 days in others.
  • Corticosteroids were tapered in all patients, with no cases of relapse during the follow-up period of 1,245 days.
  • Overall 75% received another biologic, mostly adalimumab, without evidence of liver injury.

"In this study of 36 patients with infliximab-induced liver injury, approximately half of patients were treated with steroids and the results suggest that patients receiving steroids recover more quickly," the authors concluded.

Reference:

The study titled, "Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment," was published in the Journal of Hepatology. 

DOI: https://doi.org/10.1016/j.jhep.2021.08.024

infliximab liver injury Journal of Hepatology steroids 
Source : Journal of Hepatology
Medha Baranwal
Medha Baranwal

    MSc. Biotechnology

    Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article

    More News

    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok